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Significance and impact  21 
The widespread presence of biofilms on dry surfaces in healthcare settings has been recently 22 
documented. These dry surface biofilms (DSB) present an unprecedented challenge to 23 
cleaning and disinfection processes. Here we describe a practical efficacy protocol based on 24 
an in vitro Staphylococcus aureus DSB model. The protocol measures reduction in viability, 25 
transferability and biofilm regrowth post treatment to provide altogether a practical assessment 26 
of product efficacy against dry surface biofilms.  27 
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 28 
Abstract  29 
Dry surface biofilms (DSB) harbouring pathogens are widespread in healthcare settings, 30 
difficult to detect and resistant to cleaning and disinfection interventions. Here, we describe a 31 
practical test protocol to palliate the lack of standard efficacy test methods for DSB.  32 
Staphylococcus aureus DSB were produced over a 12-day period, grown with or without the 33 
presence of organic matter, and their composition and viability were evaluated. Disinfectant 34 
treatment was conducted with a modified ASTM2967-15 test and reduction in viability, 35 
transferability, and biofilm regrowth post treatment were measured.  Dry surface biofilms 36 
produced over a 12-day period had a similar carbohydrates, proteins and DNA content, 37 
regardless the presence or absence of organic matter. The combination of sodium 38 
hypochlorite (1,000 ppm) and a microfiber cloth was only effective against DSB in the absence 39 
of organic load. With the increasing concerns of the uncontrolled presence of DSB in 40 
healthcare settings, the development of effective interventions is paramount. We propose that 41 
our DSB model in the presence of organic load is appropriate for the testing of biocidal 42 
products, while the use of three parameters, log10 reduction, transferability and regrowth, 43 
provides an accurate and practical measurement of product efficacy. 44 
 45 
keywords: dry surface biofilm, cleaning, disinfection, efficacy test, test protocol, sodium 46 
hypochlorite 47 
 48 
  49 
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Introduction 50 
 51 
Biofilms are microbial communities embedded in self-secreted extracellular polymeric 52 
substances (EPS). Biofilms are significantly more tolerant to antimicrobials when compared to 53 
their planktonic equivalents (Akinbobola et al., 2017). The vast majority of studies on biofilm 54 
resistance to disinfection concerns hydrated biofilms formed and consistently grown in liquid 55 
environments or in the presence of high level of moisture (Francolini and Donell, 2010; Bridier 56 
et al., 2011; Otter et al., 2015). Not much attention has been paid to ‘dry’ biofilms colonising 57 
surfaces with the presence of desiccated microorganisms, limited moisture and nutrient 58 
resource (Vickery et al., 2012; Almatroudi et al., 2015) despite their widespread presence on 59 
healthcare surfaces (Vickery et al., 2012; Hu et al., 2015; Ledwoch et al., 2018).  60 
There is no standardized efficacy test against biofilm published by the European Norm. In the 61 
US, disinfectant efficacy tests against biofilms concern the treatment of hydrated biofilms (US 62 
Environmental Protection Agency, 2013). Among common test protocols the Calgary device 63 
enables the measurement of the minimal biofilm eradication concentration (MBEC) which 64 
corresponds to the lowest concentration of a biocide or biocidal formulation that kill a mono 65 
species bacterial (hydrated) biofilm (Ceri et al., 1999; Ali et al., 2006; Azaredo et al., 2017); 66 
The CDC reactor model and drip flow reactor model have also been used successfully to 67 
measure the efficacy of antimicrobials against hydrated biofilms. (Schwartz et al., 2010, 68 
Almatroudi et al., 2015). Other non-standardised biofilm efficacy methods have also been 69 
described (Pierce et al., 2008; Millhouse et al., 2014; Sherry et al., 2016). There are, however, 70 
no standard protocols to measure the efficacy of biocidal formulations against dry surface 71 
biofilms (DSB).  72 
This paper proposes such a test and establishes test parameters to ensure the appropriate 73 
control of DSB in practice following cleaning/disinfection interventions. 74 
 75 
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Results and discussion 76 
 77 
Dry surface biofilms are widespread on various surfaces in healthcare facilities (Vickery et al., 78 
2012; Almatroudi et al., 2015), although their impact on healthcare associated infections has 79 
not been yet established. Bacillus spp. and Staphylococcus aureus were recently identified as 80 
the species most commonly associated with DSB formed on hospital surfaces (Ledwoch et 81 
al., 2018). Furthermore, Vickery and colleagues (2012) showed that DSB can persist on 82 
surfaces despite effective cleaning. In their study, samples isolated from ICU unit harboured 83 
pathogens including multidrug resistant microorganisms following terminal cleaning with 84 
neutral detergent followed by chlorine 500 ppm disinfection. Equipment and furnishing 85 
retrieved from hospital were also positive for the presence of VRE and MRSA (Vickery et al., 86 
2012). 87 
Here, we report the development of artificial mono-species DSB grown in the presence of 88 
organic load or not, for biocidal product testing. To date there are no such tests reported in 89 
the literature and limited existing protocols refer to testing against hydrated biofilms. The 90 
number of bacteria recovered from CL-DSB dry-biofilm or OL-DSB was the same after the 91 
formation of DSB (Fig. 1). There was no statistically significant difference (Two-way ANOVA, 92 
p=0.08821) in viable count of bacteria (log10 CFU/ml = 7.60 ± 0.60) recovered from each disc 93 
between 20 environmental DSB replicates. The average bacterial concentration in CL- and 94 
OL-DSB was 7.38 ± 0.58 and 7.89 ± 0.60 log10 CFU ml-1, respectively. S. aureus DSB 95 
composition consisted mainly of proteins (96 ± 1%) with some carbohydrates (4 ± 1%), with 96 
overall little DNA (Fig. 2).  No lipids were detected by the colorimetric sulfo-phospho-vanillin 97 
method suggesting lipid level was below the detection limit of 35 µg ml-1 (Anschau et al., 2017). 98 
The amount of proteins and carbohydrates remains constant throughout the dry surface biofilm 99 
cycles with 95-97% of proteins and 3-5% carbohydrates in both CL and OL- DSB. Surprisingly 100 
the addition of BSA during the OL-DSB production did not impact on the composition of the 101 
biofilm (Fig. 2). Indeed, there was no statistical difference (p=0.5317) between the 102 
5 
 
carbohydrate and proteins ratio of CL- and OL-DSB.  More DNA (ANOVA; p<0.05) was 103 
extracted from DSB grown in the presence of organic load (21 ± 7 ng/disc) compared to without 104 
BSA (17 ± 9 ng/disc). Hydrated S. aureus biofilms are also mostly composed of proteins, 105 
although carbohydrate concentration is higher. Abdallah et al.  (2014) reported S. aureus 24h 106 
and 48h hydrated biofilms formed on stainless steel coupons were composed of 70% and 78% 107 
proteins and 30% and 22% of carbohydrates, respectively.  108 
The composition, appearance and viability of our dry surface biofilms were homogeneous (Fig. 109 
3) with 8.0 ± 0.6 log10 CFU cm-2 after the 12 days process.  Abdallah et al. (2014) reported 110 
similar findings with hydrated S. aureus biofilms following 24h and 48 h incubation, 8.4 ± 0.2 111 
and 8.2 ± 0.2 log10 CFU cm-2, respectively. After the first dry phase, the majority of bacteria 112 
were viable (90% and 98% of all bacteria in CL- and OL-DSB, respectively) (Fig. 3). However, 113 
in the course of growth and after sequential dry phases, the number of dead bacteria increased 114 
(Fig. 3). At the end of dry surface biofilm formation cycle, 42% and 75% of bacteria were viable 115 
in CL- and OL-DSB, respectively. SEM of 12-day DSB showed homogenous cluster of bacteria 116 
embedded in a matrix and separated by channels. OL-DSB appeared to contain more matrix 117 
(Fig. 4). Although uniformity is a positive attribute for reproducibility, these biofilms differ 118 
somewhat to DSB isolated from healthcare surfaces. Indeed, environmental DSB form 119 
clusters of unevenly scattered bacteria through the colonised surface, thus making disinfectant 120 
testing using in situ dry surface biofilms inappropriate (Ledwoch et al., 2018).  121 
Considering potential product usage in practice (Sattar and Maillard, 2013), it seemed 122 
appropriate to combine the use of the wiperator (ASTM26987-15, 2015) with our DSB. The 123 
ASTM2697-15 (2015) was preferred to the EN1665-15 (2015) protocol, as it was recently 124 
shown to be a more stringent protocol (Wesgate et al., 2018). To provide a sensible and useful 125 
measurement of product efficacy against DSB, we decided to measure several criteria 126 
indicative of product efficacy: i) reduction in viability as a result of bactericidal activity or/and 127 
removal of bacteria from the surface, ii) transferability of bacteria post-wiping and iii) DSB 128 
regrowth indicating the frequency of product application needed to render the surface safe. 129 
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Using such an approach we first identified that DSB produced in the presence of OL, were 130 
more difficult to control than those produced in the absence of organic load, despite that 131 
NaOCl (1,000 ppm) in combination with the microfiber cloth decreased S. aureus number in 132 
DSB by >4 log10 (Table 1). More bacteria within DSB could be removed/killed when the biofilm 133 
was grown in the absence of organic load. Almost 6 log10 reduction was achieved which could 134 
be compared to results showed by Almatroudi et al. (2016) where more than 7 log10 of bacteria 135 
in DSB were removed/killed by treatment with 1,000 ppm NaOCl. Although, NaOCl treatment 136 
significantly lowered (Two-way ANOVA; p<0.05) the transfer of bacteria from dry surface 137 
biofilms compared to the absence of treatment, it was significantly less effective when DSB 138 
were formed in the presence of organic load (Table 1). Likewise, time for regrowth post NaOCl 139 
exposure was much shorter in the presence of organic load (Table 1). Hence, measuring 140 
additional parameters to the traditional viability one, provide additional stringency. 141 
Transferability post-treatment is particularly important to consider notably in relation to hand 142 
hygiene compliance. Indeed, DSB have been shown to be widespread in healthcare settings 143 
(Hu et al., 2015; Ledwoch et al., 2018), acting as a potential transmission reservoir. As median 144 
hand hygiene rate from 96 empirical studies is only 40% (Erasmus et al., 2010), the risk of 145 
transmitting pathogens from DSBs is high. It is thus conceivable that, despite the reduction in 146 
viability following, here, exposure to NaOCl (1,000 ppm), bacteria embedded in a dry surface 147 
biofilm can still be easily transferred. Chowdhury et al. (2018) also reported on the persistent 148 
nature of DSB; in their study, treatment with neutral detergent had a little effect on bacterial 149 
transferability from DSB. The regrowth parameter, although linked somewhat to a reduction of 150 
viability, provides information on how long the surface would be biofilm-free post treatment. 151 
We are proposing that the dry surface biofilm model formed and grown in the presence of 152 
organic load, as well as the parameters investigated, are suitable to measure the efficacy of 153 
cleaning and/or disinfectant treatments. 154 
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 155 
Materials and methods 156 
 157 
Bacterial growth and maintenance 158 
Staphylococcus aureus NCTC107888 was propagated in tryptone soya broth (TSB; Oxoid 159 
Limited, Hampshire, UK) at 37°C overnight and washed in tryptone sodium chloride following 160 
centrifugation at 1,400 xg. Tryptone sodium chloride was prepared by mixing 1 g of tryptone 161 
(Oxoid Limited, Hampshire, UK) and 8.5 g of sodium chloride (Sigma- Aldrich®, Dorset, UK) 162 
in 1 l of distilled water followed by autoclaving. The bacterial suspension was adjusted to 1 x 163 
106 cfu ml-1. 164 
 165 
Dry biofilm models 166 
The bacterial growth approach in our DSB model is based on alternating hydrated (growth) 167 
phases with desiccation phases as described by Almatroudi et al. (2015). In our model we 168 
utilised a sedimentation protocol to form and grow DSB, as described below. Bacteria were 169 
initially cultured in normal hydrated conditions to allow initial adherence and biofilm formation. 170 
This was followed by cycles of dry and hydrated phases for a total duration of 12 days (Fig. 171 
1).  172 
Stainless steel discs AISI 430 (0.7 ± 0.07 mm thickness; 10 ± 0.5 mm diameter, Goodfellow 173 
Cambridge Limited, Huntington, UK) were used as a support. Sterile discs were placed in 174 
Corning™ Costar™ flat bottom cell culture plates (Fisher Scientific, Loughborough, UK), and 175 
each well was inoculated with 1 ml of TSB containing 5% anhydrous D-glucose (Fisher 176 
Scientific, Loughborough, UK) with 106 CFU ml-1 washed S. aureus suspension. Bacteria were 177 
first allowed to attach and form a biofilm on the disc surface over 2 days period at 25°C under 178 
gentle agitation using an Orbit P4 plate rocker (Labnet International, Edison, USA); i.e. the 179 
hydrated phase. The solution was then drained from the wells and plates were incubated at 180 
37°C for 48 h. Following this dry phase, 1 ml of TSB was added into each well containing 181 
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stainless steel disc and a new ‘hydrated phase’ began for 48 h. Hydrated and dry phases 182 
alternate every 48 h for a period of 12 days, ending with biofilm in a dry phase (Fig. 1). 183 
Two models of S. aureus dry surface biofilms were developed: i) a clean (CL) DSB grown in 184 
TSB only, and ii) an organic load (OL) DSB grown in 3 gl-1 bovine serum albumin (BSA; 185 
Sigma® Life Science, Dorset, UK). BSA was added to each wet phase during the 12 days 186 
period.  187 
 188 
Biofilm composition 189 
Carbohydrate: Carbohydrate content in DSB models was measured by dinitrosalicylic (DNS; 190 
Fisher Scientific Ltd, Loughborough, UK) colorimetric assay (Miller, 1959). Briefly, disc 191 
containing biofilm was placed in McCartney bottle with 1 g of glass beads and 3 ml of sterile 192 
water. The disc was vortexed with Fisherbrand® vortex shaker (Fisher Scientific, 193 
Loughborough, UK) for 10 min prior to the analysis. Two gl-1 of phenol (Fisher Scientific Ltd, 194 
Loughborough, UK) was added to DNS reagent to intensify the colour density and increase 195 
the sensitivity of the method. Three ml of DNS reagent was added directly to vortexed culture 196 
or directly to an overnight planktonic suspension of S. aureus and covered with lid to prevent 197 
liquid evaporation. The mixture was heated for 15 min at 90°C in Fisherbrand water bath 198 
(Fisher Scientific, Loughborough, UK) until the colour developed. Colour was stabilised by 199 
adding 1 ml of 40% potassium sodium tartrate solution (Fisher Scientific Ltd, Loughborough, 200 
UK). Absorbance at 575 nm was read after the mixture cooled down to the room temperature 201 
and compared against the standard curve to evaluate carbohydrates content. 202 
 203 
Protein analysis: Discs with S. aureus DSB were placed in sterile 30 ml capacity flat bottom 204 
glass bottles containing 1g of glass beads and 2 ml of sterile water and vortexed for 10 min. 205 
The suspensions were then centrifuged in Biofuge Primo R centrifuge (Heraeus, Thermo 206 
Fisher Scientific, Newport, UK) at 1,400 g and 20°C for 10 min. The supernatant was then 207 
discarded, and the remaining bacterial pellets were weighted. Proteins were extracted using 208 
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the Total Protein Extraction Kit (Chemicon®, Millipore Limited, Watford, UK). Briefly, 2.5 ml TM 209 
buffer was added to 1 g of the pellet and put on ice for 5 min. Bacterial cells were homogenised 210 
three times by vortexing for 20 sec and incubation on dry ice for 15 sec. The mixture was then 211 
centrifuged at 11,000 g at 4°C for 20 min using Avanti™ J-20 XP centrifuge (Beckman Coulter, 212 
High Wycombe, UK). Collected supernatant was quantified for proteins content. Quantification 213 
was carried out with Folin–Ciocalteu reagent (Lowry et al., 1951) by using Pierce™ Modified 214 
Lowry Protein Assay (Thermo Scientific™, Loughborough, UK). One ml of Modified Lowry 215 
Reagent was added to each tube containing 0.2 ml of supernatant. The mixture was well 216 
homogenised with vortex shaker (Fisherbrand®, Fisher Scientific Ltd, Loughborough, UK) and 217 
incubated at room temperature for 10 min. One hundred µl of 1X Folin-Ciocalteu Reagent was 218 
then added and the sample vortexed for 5 seconds. Sample was covered and incubated for 219 
30 min at room temperature. The absorbance at 750nm was measured and the amount of the 220 
proteins in the sample was evaluated by using standard curve prepared according to 221 
manufacturer instructions using diluted albumin (BSA) standards. 222 
 223 
Lipid analysis: Lipids were extracted with the chloroform-free Lipid Extraction Kit (Abcam®, 224 
Cambridge, UK). Discs with S. aureus DSB were vortexed for 10 min in Mccartney bottles 225 
containing 1 gr of glass beads and 2 ml of sterile water. The suspensions  were then 226 
centrifuged at 1,000 g at 20°C for 5 min. Supernatant was discarded, and the pellets were 227 
washed and resuspended in 25 µl of phosphate buffer saline (PBS; 8 g of sodium chloride 228 
(Sigma- Aldrich®, Dorset, UK), 0.2 g of potassium chloride (Fisher BioReagents®, Fisher 229 
Scientific Ltd, Loughborough, UK), 1.44 g of sodium phosphate dibasic heptahydrate (Thermo 230 
Fisher Scientific, Newport, UK) and 0.24 g of potassium phosphate monobasic (Thermo Fisher 231 
Scientific, Newport, UK) in up to 1 l water). pH was adjusted to 7.4. Five hundred µl of Abcam 232 
extraction buffer containing 60% hexane and 40% isopropanol (Abcam®, Cambridge, UK) 233 
was added to the samples which were vortexed for 2 min. The mixture was agitated on Orbit 234 
P4 plate rocker (Labnet International, Edison, USA) at room temperature for 20 min. The tubes 235 
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were centrifuged for 5 min at 10,000 g and the supernatant was collected and weighted. The 236 
tube with supernatant was dried overnight in Thermo Heraeus Herasafe™ safety cabinet 237 
(Thermo Fisher Scientific, Newport, UK) at 37°C. The analysis of lipids was carried out 238 
following the colorimetric sulfo-phospho-vanillin (SPV; Fisher Scientific Ltd, Loughborough, 239 
UK) method (Cheng et al., 2011). One ml of chloroform: methanol solvent was added per 15 240 
mg of sample followed by 100 µl of sulfuric acid (Fisher Scientific Ltd, Loughborough, UK). 241 
Samples were heated at 90°C for 10 min on a stirring hotplate (Fisher Scientific Ltd, 242 
Loughborough, UK) and then placed on ice to cool them down to room temperature. One 243 
hundred µl vanillin- phosphoric acid reagent was added to the sample to develop the colour. 244 
Absorbance at 540nm was measured after 5 min to determine the lipid content.  245 
 246 
DNA analysis:  Discs with DSB were placed in 30 ml capacity flat bottom glass bottle with 1 g 247 
glass beads and 0.5 ml TSB and vortexed for 10 minutes to remove the biofilm from disc 248 
surface. 0.5 ml of 4 mol l-1 guanidine isothiocyanate (UltraPure™, ThermoFisher Scientific, 249 
Newport, UK) was added to the sample and further vortexed for 1 min. One ml of mixture was 250 
transferred to a 2 m l tube with cap and Fisherbrand® O-ring (Fisher Scientific, Loughborough, 251 
UK) with 1 g of 0.1 mm diameter zirconia/silica beads (Thistle Scientific, Glasgow, UK) and 252 
homogenised in bead bug (Benchmark Scientific, Cole-Parmer®, St Neots, UK) at 2,800 rpm. 253 
DNA amplification was carried out with Maxwell® 16 Instrument (Promega, Southampton, 254 
UK). The amount of extracted DNA was quantified with Quibit® 3.0 fluorometer (ThermoFisher 255 
Scientific, Newport, UK). 256 
 257 
Scanning Electron Microscopy (SEM) imaging 258 
S. aureus DSB samples were prepared by overnight incubation of discs in 2.5% 259 
glutaraldehyde solution (Fisher Scientific, Loughborough, UK) followed by immersion in 260 
successive concentrations of 10%, 25%, 50%, 70%, 90% and 100% ethanol (Honeywell, 261 
Fisher Scientific Ltd, Loughborough, UK) for 10 min each. Prior to SEM scanning, samples 262 
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were coated with 20 nm AuPd coating with sputter coater (SC500, Biorad, UK).  Secondary 263 
electron images were acquired with a beam energy of 5kV using an in-lens detector on a 264 
Sigma HD Field Emission Gun Scanning Electron Microscope (Carl Zeiss Ltd., Cambridge, 265 
UK) at 10,000x magnification and 5-7 mm working distance. SEM images were false-coloured 266 
to help visualisation and contrast using GNU Image manipulation program (GIMP 2.8) 267 
software. Images were not otherwise altered.  268 
 269 
Live/dead staining 270 
Staining of dry surface biofilm was carried out with LIVE/DEAD® BacLight™ bacterial viability 271 
kit (Invitrogen, Thermo Fisher Scientific, Newport, UK) with Syto 9 and propidium iodide in 1:1 272 
ratio. Prior to staining, each disc was mildly washed with 1 ml sterile water for 5 sec to remove 273 
any planktonic or loosely adhered cells. Stained discs were imaged with Zeiss LSM880 274 
Airscan Confocal Microscope (Carl Zeiss Ltd., Cambridge, UK). 275 
LIVE/DEAD cells ratios were evaluated using BioFilmAnalyzer v. 1.0 software with the 276 
procedure developed by Bogachev et al. (2018). Prior to analysis, non-homogenous colour 277 
distribution of obtained images in the studied colour channels was resolved by preliminary 278 
image colour normalization using GNU Image manipulation program (GIMP 2.8). 279 
 280 
ASTM E2967-15 test 281 
The effectiveness of sodium hypochlorite (NaOCl 1,000 ppm; Fisher Scientific Ltd, 282 
Loughborough, UK) combined with Rubbermaid® HYGEN™ disposable microfiber cloth 283 
(Rubbermaid Products, Surrey, UK) allowing 2.5 ml of disinfectant per 1 g of wipe was 284 
evaluated against CL- and OL-DSB controls consisted of untreated samples. Disinfection tests 285 
were performed according to a modified ASTM E2967 test (2015). The surface of the disc was 286 
wiped with the Wiperator (Filtaflex Ltd, Ontario, Canada) from both sides using separate 287 
wipes. Dry surface biofilms were wiped for 10 sec under 500g pressure, left at room 288 
temperature for 2 min, and then the wiped discs neutralised by placing each disc into 1 ml 289 
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Dey-Engley (DE) neutralising broth (Neogen® Corporation, Ayr, UK) for 2 min.  Inoculated 290 
broth was then incubated overnight at ambient temperature. Transfer of viable bacteria from 291 
used wipes to clean a sterile disc was not performed. 292 
Log10 reduction in bacteria embedded in DSB: Reduction in bacterial viability (Log10 reduction 293 
in CFU ml-1) gave the number of bacteria that were removed or and killed following wiping. 294 
Following wiping, samples were placed in a solution containing 1 g of glass beads (Fisher 295 
Scientific, Loughborough, UK), 2 ml DE neutralising broth and 100 µg ml-1 proteinase K (Fisher 296 
Bioreagents™, Fisher Scientific, Loughborough, UK) for 1 h at 37°C. After incubation, samples 297 
were vortexed for 2 min, serially diluted and 3 x 10 µl drops of each dilution plated onto tryptone 298 
soya agar (TSA; Oxoid, Thermo Fisher Scientific, Newport, UK). Log10 reduction was 299 
calculated as the difference between the number of bacteria recovered from untreated 300 
(control) and treated samples.  301 
 302 
Transferability test following disinfection: Transfer test was conducted to investigate the 303 
transferability of surviving bacteria from the dry surface biofilm following wiping. The test was 304 
designed to imitate the touch of a finger onto treated surface. Following wiping and 2 min 305 
contact time, discs were pressed 36 separate times with 100 g pressure on the surface of DE 306 
agar. Following the transfer test, DE agar was incubated overnight at 37°C. Positive 307 
growth/adpression was recorded and transferability calculated as the number of positive 308 
contact/number of adpressions.  309 
 310 
Dry surface biofilm regrowth test following treatment: Regrowth measures the time needed for 311 
the DSB to recover following treatment. Wiped samples were placed in 30 ml capacity flat 312 
bottom glass bottle with 2 ml of DE neutralising broth (Acumedia®, Neogen® LabM, 313 
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Lancashire, UK). The number of days for the DE broth colour to change from purple to yellow 314 
indicative of bacterial growth was recorded.  315 
 316 
Statistical analysis 317 
Statistical significance of data sets was evaluated with GraphPad PRISM® (version 7.04) 318 
using two-way ANOVA. All measurements, if not stated otherwise, were performed in 319 
triplicates. The sample standard deviation was evaluated with Bassel’s correction. 320 
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Table 1. Effectiveness of NaOCl (1,000 ppm) on clean (CL) and organic load (OL)- 
DSB. Impact of disinfectant on reduction in bacteria, transferability and 
regrowth.  
 NaOCl 1,000 ppm No treatment 
Log10 reduction in bacteria (cfu cm-2) ± SD 
CL-DSB 5.83 ± 1.25 - 
OL- DSB 4.26 ± 1.26 - 
Transferability (%) ± SD 
CL- DSB 1 ± 2 95 ± 8 
OL- DSB 68 ± 37 100 ± 0 
Regrowth (days) 
CL- DSB 5.4 ± 3.3 1 ± 0 
OL- DSB 2.8 ± 0.8 1 ± 0 
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Figure 1 Scheme of dry surface biofilm formation and growth 
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Figure 2. Composition of clean (CL; left) and organic load (OL; right) dry biofilms. 
DNA: , Carbohydrates: , Proteins: . Time “0” indicates planktonic 
bacteria. No lipids were recoved with the protocol used in this study. 
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Figure 3. Live (green)/dead(red) fluorescence images of Syto 9/propidium iodide 
stained clean dry biofilm (CL, top) and Syto 9/propidium iodide stained organic load 
dry biofilm (OL, bottom) after 4, 8 and 12 days of cultivation. x63 magnification, Zeiss 
LSM880 Airscan Confocal Microscope. Representative images from 3 fields of 2 
samples. CL-DSB after 4 (A), 8 (B) and 12 (C) days; OL-DSB after 4 (D), 8 (E) and 
12 (F) days. 
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Figure 4 Scanning electron microscope images of clean (CL) dry biofilm and organic 
load (OL) dry biofilm, x2,000 and x5,000 magnifications. Images presented are 
representative for the whole disc surface. CL-DSB at x2,000 (A) and x5,000 (B) 
magnification, OL-DSB at x2,000 (C) and x5,000 (D) magnification. 
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